WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Transplant Product Efficacy Framework v17, Graft Loss defined by following options Graft Nephrectomy, Diagnosis documents Hypertension, Solid Organ Transplant has occurence (1...n) Yes, Recipient Characteritics documents Dialysis, Glomerular Filtration Rate (GFR) is measured as decreased, Recipient Characteritics documents Panel Reactive Antibody, Clinically Suspected Acute Rejection (CSAR) recorded in Date of CSAR, Viral Status can be assessed at defined time points, Biopsy Result has option T Cell Mediated Rejection, Graft Loss is recorded at Date of Graft Loss, Therapeutic Efficacy Point is the intersection of Therapeutic Intervention, Cause of Death has option PTLD (post-transplant lymphoproliferative disorder), Biopsy Result has option Antibody Mediated Rejection, Body Suface Area (BSA) is derived from Weight, Biopsy Proven Acute Rejection (BPAR) is observed on Date of Biopsy, Serum Creatinine (SCr) is measured as increased, Observation or Assessment is used to monitor the effectiveness of Therapeutic Intervention, Donor Characteristics documents Serum Creatinine (SRc), Deceased has option Expanded Criteria Donor (ECD), Acute Rejection Grade has value BANFF Grade